Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 11401-11450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05781789
Redesigning Pre-surgery Patient Journeys With Telehealth
N/A
Active, not recruiting
258 participants
Started: Jul 13, 2021 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT05165225
Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial
PHASE2
Active, not recruiting
48 participants
Started: Jul 13, 2021 · Completed: Mar 31, 2028
4 conditions
2 sponsors
1 location
NCT04690998
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients
NA
Active, not recruiting
104 participants
Started: Jul 13, 2021 · Completed: Oct 8, 2025
1 condition
1 sponsor
11 locations
NCT04551131
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Jul 13, 2021 · Completed: Aug 31, 2026
1 condition
4 sponsors
13 locations
NCT04908202
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
PHASE3
Active, not recruiting
670 participants
Started: Jul 13, 2021 · Completed: Jun 10, 2027
1 condition
1 sponsor
183 locations
NCT05018286
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
PHASE3
Active, not recruiting
158 participants
Started: Jul 13, 2021 · Completed: Oct 30, 2027
1 condition
1 sponsor
66 locations
NCT04510792
IMpact of HyPeRkalaemia on ThErapy with Renin AngiotenSin AldoSterone System Inhibitors
N/A
Active, not recruiting
100 participants
Started: Jul 12, 2021 · Completed: Nov 30, 2024
1 condition
2 sponsors
1 location
NCT04629729
FT819 in Subjects With B-cell Malignancies
PHASE1
Active, not recruiting
54 participants
Started: Jul 12, 2021 · Completed: Sep 30, 2039
3 conditions
1 sponsor
17 locations
NCT04939142
A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE3
Active, not recruiting
150 participants
Started: Jul 12, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
33 locations
NCT04937400
Delirium in Children Undergoing Stem Cell Transplantation
N/A
Active, not recruiting
1,040 participants
Started: Jul 12, 2021 · Completed: Jul 31, 2026
2 conditions
2 sponsors
6 locations
NCT04636814
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
PHASE3
Active, not recruiting
3,973 participants
Started: Jul 12, 2021 · Completed: Dec 26, 2025
1 condition
1 sponsor
460 locations
NCT04926948
Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma
PHASE1
Active, not recruiting
20 participants
Started: Jul 12, 2021 · Completed: May 25, 2026
1 condition
1 sponsor
1 location
NCT04857034
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
PHASE2
Active, not recruiting
74 participants
Started: Jul 12, 2021 · Completed: Feb 28, 2028
2 conditions
1 sponsor
41 locations
NCT04972838
AIR-B4: Remaking Recess (RR)
NA
Active, not recruiting
264 participants
Started: Jul 11, 2021 · Completed: Dec 1, 2025
2 conditions
7 sponsors
3 locations
NCT04856085
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
PHASE2
Active, not recruiting
244 participants
Started: Jul 11, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
37 locations
NCT04692103
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
PHASE2
Active, not recruiting
2 participants
Started: Jul 10, 2021 · Completed: Apr 30, 2041
3 conditions
1 sponsor
1 location
NCT05006157
Pericardial Access With ViaOne Device
NA
Active, not recruiting
10 participants
Started: Jul 10, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
4 locations
NCT06979921
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
N/A
Active, not recruiting
496 participants
Started: Jul 10, 2021 · Completed: Dec 30, 2026
1 condition
2 sponsors
2 locations
NCT04951219
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
PHASE3
Active, not recruiting
1,000 participants
Started: Jul 9, 2021 · Completed: Apr 30, 2026
1 condition
1 sponsor
71 locations
NCT04985500
ESP/PIF for Sternotomy
EARLY_PHASE1
Active, not recruiting
225 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05213234
Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
NA
Active, not recruiting
32 participants
Started: Jul 9, 2021 · Completed: Mar 31, 2026
1 condition
2 sponsors
2 locations
NCT03684564
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
PHASE2
Active, not recruiting
43 participants
Started: Jul 9, 2021 · Completed: Aug 31, 2025
5 conditions
8 sponsors
6 locations
NCT04808752
Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
PHASE2
Active, not recruiting
63 participants
Started: Jul 9, 2021 · Completed: Jul 15, 2024
1 condition
2 sponsors
1 location
NCT06325072
Set-up of a Platform for Personalized Diagnosis of Rare Kidney Diseases (NIKE)
NA
Active, not recruiting
160 participants
Started: Jul 9, 2021 · Completed: Jun 30, 2024
1 condition
1 sponsor
4 locations
NCT04948203
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
PHASE2/PHASE3
Active, not recruiting
60 participants
Started: Jul 9, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04408495
Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications After On-pump Cardiac Surgery in High-risk Patients
NA
Active, not recruiting
440 participants
Started: Jul 8, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
10 locations
NCT04415424
Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men
PHASE3
Active, not recruiting
650 participants
Started: Jul 8, 2021 · Completed: Oct 30, 2025
1 condition
2 sponsors
7 locations
NCT04920097
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
NA
Active, not recruiting
225 participants
Started: Jul 8, 2021 · Completed: May 30, 2026
1 condition
3 sponsors
2 locations
NCT04949113
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
PHASE3
Active, not recruiting
423 participants
Started: Jul 8, 2021 · Completed: Dec 19, 2028
1 condition
2 sponsors
24 locations
NCT04829994
Post-Market Clinical Follow-Up onTVT EXACT® Continence System
N/A
Active, not recruiting
198 participants
Started: Jul 8, 2021 · Completed: Feb 28, 2036
1 condition
1 sponsor
8 locations
NCT04976959
High Fiber in Parkinson's Disease
PHASE1
Active, not recruiting
60 participants
Started: Jul 8, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05105854
Hand Osteoarthritis: Investigating Pain Trajectories and Association With Biomarkers Including Estrogen Cohort
N/A
Active, not recruiting
120 participants
Started: Jul 7, 2021 · Completed: Feb 7, 2029
1 condition
2 sponsors
2 locations
NCT04871308
Dexmedetomidine and Myocardial Protection
NA
Active, not recruiting
224 participants
Started: Jul 7, 2021 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT04918420
A Single-arm Trial of the Flow Diverter (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms
NA
Active, not recruiting
142 participants
Started: Jul 7, 2021 · Completed: Mar 31, 2027
1 condition
1 sponsor
7 locations
NCT05044819
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
PHASE4
Active, not recruiting
154 participants
Started: Jul 7, 2021 · Completed: Mar 31, 2028
3 conditions
2 sponsors
19 locations
NCT04868266
End Tidal Carbon Dioxide in Minimal Sedation
NA
Active, not recruiting
214 participants
Started: Jul 7, 2021 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT04817761
SPARK-ALL: Calaspargase Pegol in Adults With ALL
PHASE2/PHASE3
Active, not recruiting
122 participants
Started: Jul 7, 2021 · Completed: Feb 9, 2026
1 condition
2 sponsors
19 locations
NCT04950283
MR-based Characterization of Bone Marrow in Its Relevance to Skeletal Disease in Patients With Diabetes
N/A
Active, not recruiting
85 participants
Started: Jul 7, 2021 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04981496
Novel ICD Arrhythmia Detection Algorithm
N/A
Active, not recruiting
90 participants
Started: Jul 6, 2021 · Completed: May 1, 2024
3 conditions
1 sponsor
1 location
NCT06155409
Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease
N/A
Active, not recruiting
148 participants
Started: Jul 6, 2021 · Completed: Jul 31, 2027
1 condition
2 sponsors
6 locations
NCT04929470
Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
N/A
Active, not recruiting
30 participants
Started: Jul 6, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
3 locations
NCT04062552
Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers
NA
Active, not recruiting
208 participants
Started: Jul 6, 2021 · Completed: Jun 23, 2026
3 conditions
2 sponsors
113 locations
NCT05043857
Stereotactic PAncreatic RadioTherapy Adjuvant Therapy
NA
Active, not recruiting
50 participants
Started: Jul 6, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT04862078
Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer
NA
Active, not recruiting
368 participants
Started: Jul 6, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05043103
Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients with Advanced Parkinson's Disease
N/A
Active, not recruiting
300 participants
Started: Jul 6, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
56 locations
NCT04926142
Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study
N/A
Active, not recruiting
250 participants
Started: Jul 5, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
4 locations
NCT04786015
Active Surveillance Reporting to Identify Adverse Events Following Chiropractic Care in Older Adults
N/A
Active, not recruiting
900 participants
Started: Jul 5, 2021 · Completed: Jul 31, 2025
2 conditions
4 sponsors
1 location
NCT04844931
Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction
NA
Active, not recruiting
250 participants
Started: Jul 5, 2021 · Completed: Jul 1, 2030
1 condition
2 sponsors
11 locations
NCT04883957
Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies
PHASE1
Active, not recruiting
64 participants
Started: Jul 5, 2021 · Completed: Apr 30, 2026
1 condition
1 sponsor
11 locations
NCT04632290
Brain-controlled Spinal Cord Stimulation in Patients With Spinal Cord Injury
NA
Active, not recruiting
3 participants
Started: Jul 4, 2021 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
Previous
1
More pages
226
227
228
229
230
231
232
More pages
431
Next